Kalamazoo Company Announces New Drug Target For DiabetesMetabolic Solutions Development Co. LLC announced Wednesday the publication of data in the latest issue of the scientific journal PLOS ONE on a new drug target for treating type 2 diabetes by boosting the body's sensitivity to insulin.
UM Center For Geospatial Medicine Gets Federal Grant To Study Diabetes

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen